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3PREFACE
The rapid spread of new psychoactive substances in the EU market is one of the main challenges to be ad-
dressed by drugs policy. New psychoactive substances, which imitate the effects of illicit drugs without being 
controlled under the UN Conventions on Drugs (hence the name ‘legal highs’), can cause serious harm to the 
people who use them.
More than 350 new psychoactive substances have been detected in the EU. The problem has worsened greatly 
in recent years: the number of substances notified through the EU Early Warning System, managed by the Eu-
ropean Monitoring Centre for Drugs and Drug Addiction, more than tripled between 2009 and 2013, from 24 
to 81 a year. The speed with which new substances are entering the market to replace those that are banned 
challenges the capacity of policymakers to respond.
Another major challenge is the lack of knowledge on these substances, most of which have recently appeared 
on the market and have never been tested on humans. In September 2013, the European Commission pre-
sented legislative proposals to strengthen the EU response to new psychoactive substances. Those proposals 
underline the need to support the development, sharing and dissemination of information and knowledge in 
this field. 
The European Commission has provided support to projects on new psychoactive substances through five EU 
financial programmes, namely the Drug Prevention and Information Programme 2007-2013, Prevention of 
and Fight against Crime Programme 2007-2013, Health Programme 2008-2013, and the Sixth and Seventh 
Framework Programmes for research. The results of these projects — some of which are yet to be complet-
ed — provide useful insights into the detection and identification of these substances, their effects and risks, 
patterns and prevalence of use, or innovative prevention methods, for instance. 
This document presents an overview of the projects relating to new psychoactive substances that have re-
ceived funding from EU financial programmes since 2007. The purpose is to map out the available research, 
disseminate the results and encourage the development of evidence-based policies on new psychoactive sub-
stances.
Anti-Drugs Policy Coordination Unit
Directorate General for Justice
European Commission
June 2014
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Drug Prevention and Information Programme 2007-2013
The Drug Prevention and Information Programme 2007-2013 (DPIP), with a budget of € 21 million, provided 
financial support to more than 40 drug-related projects. Eight of those projects dealt with new psychoactive 
substances. The overall aim of the DPIP was to support the exchange of best practices across the EU to improve 
the quality of prevention and treatment services, and to reduce drug use and drug-related health damage. 
http://ec.europa.eu/justice/grants/programmes/drug/index_en.htm 
Health Programme 2008-2013
The Second Programme of Community Action in the Field of Health 2008-2013 had three main objectives: 
improve citizens’ health security, promote health and reduce health inequalities, and generate and disseminate 
health information and knowledge. It had a budget of € 321 500 000. Three projects related to new psycho-
active substances have been funded from this programme.
Prevention of and Fight against Crime (ISEC) 2007-2013
Prevention of and Fight against Crime (ISEC) 2007-2013 aimed at contributing to citizens’ security through 
projects designed to prevent and combat crime. It had a budget of € 600 million. It financed two projects re-
lated to new psychoactive substances, focused on reducing their supply. 
http://ec.europa.eu/dgs/home-affairs/financing/fundings/security-and-safeguarding-liberties/prevention-of-
and-fight-against-crime/index_en.htm 
The Sixth Framework Programme for Research 2002-2006
The Sixth Framework Programme for Research and Technological Development (FP6) encompassed the EU’s 
activities in the field of science, research and innovation. Its main aims were to support cooperation in the field 
of research, promote mobility and coordination, and harness research and innovation in the service of other EU 
policies. It had a total budget of € 17.5 billion. It funded one project on new psychoactive substances. 
http://ec.europa.eu/research/fp6/index_en.cfm 
The Seventh Framework Programme for Research 2007-2013
The Seventh Framework Programme for Research and Technological Development (FP7) was the EU’s main in-
strument for funding research and innovations. It had a total budget of € 53.2 billion. It financed three projects 
related to new psychoactive substances.
http://ec.europa.eu/research/fp7/index_en.cfm
 fi i l r r   
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SPICE
▶  ‘Spice’ and synthetic cannabinoids: fast responses by means of forensic, toxicological 
and socio-scientific analysis with direct impact on prevention measures
Research project aimed at ensuring a scientific knowledge base with a contribution to mass spectromet-
ric libraries, assessment of toxicological properties and risk profiles, and development of bioanalytical 
methods, which is important in the detection process and in acquiring information on health risks. This 
information is supplemented with data from socio-scientific analysis of use patterns, prevalence and 
health and social risks, resulting in a proposal for the most suitable preventive action.
Testing carried out on six substances (AM-694, JWH-
210, JWH-018, JWH-073, JWH-122 and CP-47 497-C8) 
suggested that there was a risk of DNA and chromo-
somal damage after use of some of the compounds, 
potentially causing specific health risks, particularly for 
habitual consumers. Furthermore, studies on mouse and 
human brain tissue showed that consumption of the in-
vestigated compounds produces effects on a neuronal 
level suggesting impairment of cognitive functions.
  
The major metabolites of seven synthetic cannabinoids 
(JWH-018, JWH-073, JWH-081, JWH-122, JWH-210, 
JWH-250 and RCS-4) were identified and structurally 
characterised. The method applied was necessary to 
isolate compounds not available as reference standards. 
Analytical methods for the detection of synthetic can-
nabinoids in serum, oral fluid and hair were developed, 
validated and published. Techniques for direct analysis 
of solid drug material were developed and evaluated, 
as portable devices and small instruments seem to be 
most suitable for on-site testing.
As a result of surveys and the information gained from 
prevention organisations, a proposal for preventive in-
terventions was drawn up, entailing development of a 
prevention website targeting users, parents and profes-
sionals, on-line counselling, a telephone hotline, website 
outreach work and other activities.
Websites:
Prevention website// https://legal-high-inhaltsstoffe.de/en 
International Conference on SPICE Prevention Issues // 
http://www.uniklinik-freiburg.de/rechtsmedizin/forschung/forensische-toxikologie/spice-conference.html 
Synthetic Cannabinoids: Brochure for professionals // 
https://legal-high-inhaltsstoffe.de/de/information/flyerdownloads.html 
Duration :
24 months (01/01/2011 to 31/12/2012)
EU Contribution : € 401 716.14
Project Coordinators :
Dr Volker Auwärter
University Medical Center Freiburg
Institut für Rechtsmedizin,
Albertstr. 9, D-79104, Freiburg
volker.auwaerter@uniklinik-freiburg.de 
Partners :
Goethe-University Frankfurt, DE
Medical University of Vienna, AT
University of Helsinki, Hjelt Institute, FI
Associated partners :
Federal Criminal Police Office Wiesbaden, DE
National Bureau for Drug Prevention, PL
National Institute for Health and Welfare, FI
City of Frankfurt, Drugs Department, DE
University of Bern, CH
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SPICE II PLUS
▶  New synthetic cannabinoids and stimulants – evaluating risk behaviours, problematic 
use and toxicity for developing specific approaches in primary and secondary prevention
The project aims to continue research initiated by the SPICE project, adding information on more sub-
stances like new stimulant drugs. Besides the development of bio-analytical methods for the detection 
of new psychoactive substances (NPS) in products and in blood or urine specimens, the project will also 
seek to acquire better knowledge on associated risks, including descriptions of users. The prevention 
strategies developed in the SPICE project will be evaluated and improved.
Based on the results of the SPICE project, health risks 
will be elucidated by characterising the type of dam-
age, the underlying mechanisms and the detoxification 
pathways. Gaseous exposure experiments with synthet-
ic cannabinoids using lung cells will assess cytotoxic/
genotoxic effects under realistic exposure conditions. 
Some fundamental pharmacological properties of new 
synthetic cannabinoids in vitro and in vivo will be char-
acterised (type of CB1 agonism).
From the social science perspective, identification and 
monitoring of new trends, patterns of use and problems 
and health risks connected to the use of NPS will be 
studied. Evaluation of data collected from a prospective 
study of emergency cases will complement the results 
of the online survey.
A triangulation of the different perspectives will be used 
to facilitate the development and implementation of in-
novative and effective prevention and harm reduction 
strategies. For this purpose an E-health intervention 
will focus on specific groups of users. The evaluation 
of these preventive measures is aimed at providing 
best-practice models for approaches to users of NPS 
and, taking into account the use of other drugs, the pro-
ject also addresses specifics of poly-drug use.
Website:
Prevention website // https://legal-high-inhaltsstoffe.de/en
Duration :
36 months (01/01/2013 to 31/12/2015)
EU Contribution : 768 808.77 EUR
Project Coordinators :
Dr Volker Auwärter
University Medical Center Freiburg
Institut für Rechtsmedizin,
Albertstr. 9, D-79104, Freiburg
volker.auwaerter@uniklinik-freiburg.de 
Partners :
University Medical Center Freiburg, DE
 Goethe-University Frankfurt, Centre for Drug 
Research, DE
 Medical University Vienna, Institute of Cancer 
Research, AT
 University of Helsinki, Department of Forensic 
Medicine, FI
Basis e.V., Frankfurt, DE
Institute for Therapy Research, DE
Associated partners :
Federal Criminal Police Office Wiesbaden, DE
National Institute for Health and Welfare, FI
 University of Bern, Institute of Forensic Medi-
cine, CH
City of Frankfurt, Drugs Department, DE
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NADPI
▶  New approaches in drug policy and interventions
The NADPI project aims to strengthen the evidence base of European drug policymaking by expanding 
the knowledge base and exchanging best practices on a number of key policy dilemmas related to de-
mand reduction, prevention and harm reduction strategies. This project is a continuation of an initiative 
by International Drug Policy Consortium and the Transnational Institute on ‘Evaluation and prospects of 
international drug control’.
The project brings the areas of practice, research and 
policy together in a series of expert seminars and infor-
mal policy dialogues to address some of the most chal-
lenging drug policy dilemmas on the European agen-
da. NADPI aims to bring technical detail into the policy 
debate to ensure that choices are evidence-based and 
outcomes pragmatic and constructive. NADPI activities 
strengthen collaboration between authorities, public 
services and NGOs and facilitate civil society involve-
ment in the implementation of the EU Drug Strategy 
and Action Plan.
The main themes on which the project focuses include:
•  the European stimulants market, more specifical-
ly the development of dependence risk reduction 
strategies to prevent problematic cocaine use pat-
terns and the development of policy responses to 
better manage changes in the stimulants market 
occurring due to the appearance of NPS;
•  the changing landscape of EU drug policymaking as 
a result of the Lisbon Treaty;
•  options to redefine the role of law enforcement in 
synergy with a health and harm reduction policy 
framework;
•  the costs and benefits of existing and potential fu-
ture cannabis regulation models.
Operating guidelines ‘Beyond the disease model, new 
perspectives in harm reduction: towards a self regula-
tion and control model’ have been developed, focusing on the relationships between cocaine users’ natural 
self-regulation strategies and controlled patterns of use and harm reduction approach, mission and services 
systems. 
Website:
http://www.undrugcontrol.info/en/about-us/about-us/item/5323-nadpi
Duration :
 12 months (from 01/01/2013  
to 31/12/2014)
EU Contribution : € 468 699.92
Project Coordinators :
Tom Blickman
Transnational Institute, NL
25 De Wittenstraat, 1052 AK, Amsterdam
tblick@tni.org 
Partners :
International Drug Policy Consortium, UK
Association Diogenis, EL
Forum Droghe
Associated partners :
CVO-Addiction Research Centre, NL
Scotisch Drug Forum, UK
State University of Florence, IT
VEZA, CZ
CNCA, IT
Romanian Harm Reduction Network, RO
CoopLotta, IT
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Euro-DEN
▶  European drug emergencies network
Euro-DEN is a project that aims to gather and analyse data on acute toxicity associated with use of 
recreational drugs and NPS, and to improve acute toxicity management by training staff working in rec-
reational settings.
An Internet survey of the REITOX network of National 
Focal Points on Drugs and other key stakeholders was 
conducted to determine what data are being collected 
at national level and to identify areas of best practice 
for data collection. This confirmed that there is limited 
systematic collection of data on acute drug/NPS toxicity. 
The Euro-DEN network of sentinel centres facilitates 
data collection, using a minimum dataset tool of param-
eters to capture the most clinically important aspects of 
acute drug and NPS toxicity (demographics, drugs used, 
clinical effects, management and outcome of the cas-
es). For 12 months (October 2013 – September 2014), 
14 hospital emergency rooms in ten countries in Europe 
will collect these data, which will be collated at the lead 
centre in London, enabling analysis of geographical and 
time trends, clinical patterns and impact of acute drug/
NPS toxicity.  
Previous studies have shown that the management of 
acute drug and NPS toxicity by those working in night-
time and other recreational settings (e.g. bars, night-
clubs, festivals) can be sub-optimal. During the second 
year of the Euro-DEN project, training of people working 
in recreational settings will take place in Estonia, Nor-
way, Spain and the UK. The training will include practical 
first aid and the use of guidelines to identify individu-
als with significant acute drug toxicity, requiring further 
clinical assessment in emergency rooms. 
Article:
D.M. Wood et al. (2014) The European Drug Emergen-
cies Network (Euro-Den). Clinical Toxicology, Vol. 52, No. 
4: Pages 239-241 // 
http://informahealthcare.com/doi/abs/10.3109/15563650.2014.898771?journalCode=ctx 
Duration :
 24 months (from 01/10/2012  
to 01/10/2014)
EU Contribution : € 393 718.32
Project Coordinators :
Dr Paul Dargan and Dr David Wood
Guy’s and St Thomas’ NHS Foundation Trust
London, UK
david.wood@gstt.nhs.uk, 
paul.dargan@gstt.nhs.uk 
Partners :
Ulleval University Hospital, NO
Hospital Universitari Son Espaces, ES
 Sdružení Podané ruce (Helping Hands Associa-
tion), CZ
 York Teaching Hospital NHS Foundation Trust, UK 
Hospital Clinic, Barcelona, ES
Technical University of Munich, DE
Pärnu Hospital, Pärnu, EE
Bispebjerg Hospital, DK
Our Lady of Lourdes Hospital, IE
Mater Misericordiae University Hospital, IE
Medical University of Gdansk, PL
Lariboisière Hospital, FR
Associated partners :
University Hospital, Basel, CH
North Estonia Regional Hospital, Tallinn, EE
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LOCAL-PASS
▶  A local approach towards the reduction of psychoactive substance use
The general aim of the LOCAL-PASS project is to reduce the use of psychoactive substances and related 
harm in Europe, by developing effective, standardised local approaches to combat psychoactive sub-
stance use. The project is expected to produce tools which will help identify and assess the potential risks 
of new developments at local level, while also providing guidelines for rapid response. 
Thematically the project covers two profiles:
•  the consumption of new psychoactive substances 
which are not controlled but which may pose health 
and social risks at a local level;
•  the consumption of controlled substances that are 
used in a different way and/or by different people.
When it comes to newly emerging trends, there is a 
significant ‘gap’ between the information available at 
national and EU levels and the information required 
for local policymaking and intervention strategies. As 
local developments are only visible at the micro-level, 
a guideline will be drawn up targeting local communi-
ties for standardised, rapid and effective identification 
of new developments in the field of psychoactive sub-
stance use.
The outcomes of national and European risk assess-
ment procedures are not always representative of the 
local situation. The probability that some harm may oc-
cur at a national level is very low, whereas it could be 
a major problem at the local level. A simple and fast 
tool for assessing the risks of new developments with-
in their region will be available to local organisations, 
helping communities to decide on the most suitable in-
tervention.
A swift response to developments is important, because it maximises the chances of success and, due to the 
local scale of the intervention, the costs are as low as possible. Therefore, guidelines in respect of predefined 
and standardised interventions for different situations and target groups will be prepared.
It is planned to disseminate results of the project to municipalities, care organisations, policymakers, research-
ers, prevention professionals and other interested partners across Europe.
Website:
www.localpass.eu
Duration :
 24 months (from 01/11/2012  
to 31/10/2014)
EU Contribution : € 454 017.27
Project Coordinators :
Mariken Hulscher
Norvadic-Kentron, 
Hogedwarsstraat 3, 5761 LX, Vught, NL
mariken.hulscher@novadic-kentron.nl   
Partners :
Association Our World, BG
Charles University of Prague, CZ
Local Health Bologna, IT
Emilia Romagna Region, IT
Municipality of Agueda, PT
ADPES, PT
Tilburg University, NL
Municipality of Breda, NL
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I-TREND
▶  Internet tools for research in Europe on new drugs: interdisciplinary and integrated 
approaches to substances, users and markets
I-TREND is a research project that aims to provide in-depth information on health and social risks linked 
to NPS sold on the Internet. A further aim is to provide experts involved in risk assessment procedures on 
NPS and forensic laboratories with a sustainable observation tool for interdisciplinary research on drugs. 
This tool is intended to help researchers identify and monitor new trends and patterns in the consump-
tion of NPS. 
The project covers four main research areas :
Analyses of drug forums – overview of users’ inter-
ests in specific substances, knowledge of NPS and its 
role in influencing harm reduction activities, compari-
son of attitudes towards NPS and current legal and il-
legal substances, evaluation of drug forums to predict 
emerging substances and trends in use.
Toxicological analysis – analysis of NPS samples 
purchased on the Internet in five EU Member States 
participating in the I-TREND project.
Online survey – patterns of use of NPS compared to 
illicit substances, motivation to use NPS and knowledge 
about risks and harm, perception of online purchasing.
Analyses of online shops – the most marketed sub-
stances, list of the online shops selling NPS in each 
partner country, overview of online market, including 
marketing strategies with respect to pricing and sale 
strategy adapted to specific age groups, control meas-
ures and restrictions.
The results obtained from these research activities will be synthesised into technical folders, of which there will 
be between 20 and 100, aimed at providing information to stakeholders such as those working in the field and 
with users. The folders should include information on use patterns, dosage, risks, effects, marketing strategies 
and availability, toxicological composition of substances purchased.
Website:
www.i-trend.eu
Duration :
 24 months (from 01/04/2013  
to 31/03/2015)
EU Contribution : € 317 555.91
Project Coordinators :
Bertrand Redonnet
 French Monitoring Centre for Drugs and Drug 
Addiction
www.ofdt.fr 
 
Partners :
 Centre for Addictology at the First Faculty of Medi-
cine, Charles University, CZ
University of Social Sciences and Humanities, PL 
Trimbos Institute, NL
Liverpool John Moores University, UK
Drug Prevention and Information Programme 2007 - 2013
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New Psychoactive  
Substances among Problem 
Drug Users : Towards effective and 
comprehensive health responses in Europe
The project aims to develop innovative methodologies for identifying and monitoring new trends and patterns 
in NPS consumption among problem drug users and related adverse consequences in order to develop target-
ed approaches to prevention, harm reduction and treatment, focusing on problem drug use.
Keywords of the project are research, practice and capac-
ity building. The project combines research capacity with 
the expertise of a European network of drug and health 
services. It will enable grass-roots organisations to assess 
NPS use among problem drug users (PDUs) and to develop 
and implement tailored responses. 
Specific objectives of the project are to:
•  provide an overview of the use of NPS in populations of 
PDUs in the 28 EU countries and to identify the associat-
ed risks for harm, and the existing legislative, preventive 
and harm reduction responses; 
•  assess, identify and describe harmful patterns of NPS use 
among PDUs, NPS-related risks and harm in five selected 
countries, as well as identify and prepare adequate tai-
lored public health responses; 
•  develop and implement targeted pilot interventions for 
prevention, demand reduction and harm reduction tar-
geting NPS use among PDUs; 
•  build best practice guidance and capacity among harm 
reduction workers with a view to improving harm reduc-
tion responses; and disseminate the results of the Eu-
rope-wide inventory, 5-country assessment and local pilots on public health responses, through an online resource 
centre and a training manual, and also at regional and national conferences.
Duration :
 24 months (01/01/2014 to 01/01/2016)
EU Contribution : € 403 728.00
Project Coordinators :
Jose Queiroz 
Piaget Agency for Development (APDES)
jose.queiroz@apdes.pt 
Partners :
Charles University in Prague, CZ
Foundation The Rainbow Group, NL
PRAKSIS, EL
Carusel, RO
Sananim, CZ
Monar, PL
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EU-MADNESS 
▶  Europe-wide monitoring, analysis and knowledge dissemination on novel/emerging psy-
choactive substances: integrated monitoring and profiling to prevent health harm and 
update professionals
The EU-MADNESS project will focus on NPS scientific and toxicological studies to provide data for detec-
tion, associated effects and health risks. The resulting feedback will improve education and prevention 
knowledge relating to the types of NPS emerging in Europe, their associated characteristics and potential 
harmful effects. 
Initially data from several countries on medical con-
sequences, e.g. fatalities, non-fatal overdoses associ-
ated with ingestion of new psychoactive substances 
will be collected. These reports will inform the choice 
of compounds to be investigated further. It is planned 
that a number of validated, robust and easily accessi-
ble models of compounds will facilitate predictions of 
neuro-pharmacological activity of unknown substanc-
es based on spectral, biological and chemical data de-
rived from known drugs of abuse. These models will 
be incorporated into the software in hand-held Raman 
spectrometers which can be used in the field. This will allow front-line healthcare providers to access detailed 
information to assist with rapid response in treatment.
Affinity of new psychoactive substances will be tested to determine their relative efficacy versus standards 
such as cocaine, amphetamine-like drugs and LSD. Their neurochemistry in vitro will be compared with that of 
cocaine and amphetamine. The data from microdialysis studies will augment the knowledge acquired from in 
vitro studies as these studies will provide data relating to the index NPS metabolism and ability to cross the 
blood brain barrier. 
Behavioural studies will shed some light on the chronic effects of a range of NPS, which may putatively cause 
permanent cognitive disturbances and increased impulsivity as well, which is crucial information for risk as-
sessment.
A range of educational tools will be produced in a range of EU languages, e.g. lectures, online teaching and 
e-learning resources for integrated spiral curricula on the health risks of NPS for use in inter-professional med-
ical, psychology, psychiatry, pharmacy, social work and health education settings.
Website:
http://www.madnessproject.org/ 
Duration :
24 months (01/04/2014 to 01/04/2016)
EU Contribution : € 635 215.29
Project Coordinators :
Prof Fabrizio Schifano, UK
University of Hertfordshire 
Drug Prevention and Information Programme 2007 - 2013
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PSYCHONAUT WEB  
MAPPING PROJECT
Two-year EU funded project focused on developing a web scanning system to identify and categorise 
novel recreational drugs and psychoactive compounds, and new trends in drug use based on information 
available on the Internet. In the absence of any scientific and toxicology study, the project’s technical 
reports provided an accurate picture of the effects, side-effects and users’ experience of NPS.
There have been 412 NPS (151 chemical, 121 herbal) 
and combinations (140) identified from the multilingual, 
exploratory qualitative searches conducted in each of 
the participating countries, and incorporated into the 
online database in the password-protected area of the 
Psychonaut Web Mapping website. Overall, the project 
was able to set up an integrated mapping and moni-
toring system on the Internet, which allowed the early 
identification of emerging trends in recreational drug 
abuse. 
The web scanning system website operated as a mech-
anism for establishing and communicating with key 
professional and scientific networks, as well as being 
a means of disseminating project results and providing 
information about upcoming conferences and publica-
tions. 
Moreover, the project has demonstrated that it is pos-
sible to rely on the information available and shared on 
the Internet to build up a reasonably accurate under-
standing of the characteristics of these novel and rec-
reational compounds. This information is vital for many 
health professionals and the online database and tech-
nical reports are helping to fill this gap in knowledge.
Website:
http://www.psychonautproject.eu
Duration :
 24 months (from 01/01/2008 to 31/12/2009)
EU Contribution : € 388 884.90 
Project coordinator:
Fabrizio Schifano;
 Institute of Psychiatry, King’s College London, UK
Partners:
University of Hertfordshire, UK
A-Clinic Foundation, Helsinki, FI
De Sleutel, Brussels, BE
Bergen Clinics Foundation, Bergen, NO
 Addiction Research Group, Department of Psy-
chiatry and Psychotherapy, LVR-Hospital, 
Essen, DE
Servizio Salute Regione Marche, Ancona, IT
 Institut Municipal d’Assistencia Sanitaria (IM-
IM-IMAS), Barcelona, ES
Health Programme 2008 - 2013   
14
ReDNet 
▶  Recreational Drugs European Network
The ReDNet was a multinational project aimed at identifying and researching NPS and providing 
evidence-based information to risk groups, healthcare providers and policymakers using a number of 
innovative information communication technologies (ICTs) (e.g. SMS, social networking sites, Second Life 
and other multimedia platforms). 
ReDNet relied on the experience gained from Psychonaut 
Web-mapping in 2010 and was able to improve intelli-
gence and generate original data on the availability and 
misuse of more than 700 NPS by monitoring the Internet 
on a daily basis in eight different languages and dissem-
inating evidence-based information via ICTs. The project 
provided evidence-based information to health profes-
sionals on prevention and harm reduction ac-
tivities using ICTs, and highlighting the fact 
that new technologies can be used in pre-
vention, although further research on the 
best approach must be conducted. 
The main phases of ReDNet:
•  content development part included: an exten-
sive multilingual literature review with respect to NPS 
misuse, an EU-wide survey on the level of knowledge 
and current sources of information about NPS, the es-
tablishment of reference groups of professionals and 
young people to assess the information presented and 
the feasibility of the technology, prior piloting.
•  technical development and piloting of a variety of 
tools were developed to better disseminate informa-
tion to target audiences — users, potential users, as 
well as professionals. It included tools as videos for 
Youtube, virtual seminaries in Second Life, Facebook 
profile, SMAIL mobile application and News Bites blog.
•  besides information disseminated using developed 
ICT, project group prepared scientific publications and 
a large number of presentation in conferences.
In 2013 the project received the European Health Award at the European Health Forum Gastein.
Websites:
http://www.rednetproject.eu/ 
http://www.clipshow.info/?lang=en/
Duration :
24 months (01/04/2010 to 31/03/2012)
EU Contribution : € 449 663.00
Project Coordinators :
Fabrizio Schifano
 University of Hertfordshire Higher Education Corpo-
ration
College Lane, PO-BOX , UK
f.schifano@herts.ac.uk  
Partners:
 National Addiction Centre, Institute of Psychiatry, 
King’s College London, UK 
Institute of Psychiatry and Neurology, Warsaw, PL
Bergen Clinics Foundation, NO
De Sleutel, Gent, BE
Servizio Salute Regione Marche, Ancona, IT
Consorci Mar Parc de Salut de Barcelona, ES
University of Duisberg-Essen, Essen, DE
 National Institute for Drug Prevention, Institute for 
Social Policy and Labour, Budapest, HU
DrugScope, London, UK 
Health Programme 2008 - 2013   
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NEWIP 
▶  New implementation nightlife empowerment and well-being
The NEWIP project brought together networks of health, prevention and harm reduction experts, regional 
authorities, field workers and volunteers to address drug problems from the practical side using recrea-
tional settings as initial outreach locations in order to respond to emerging trends.
Several supplementary sub-projects or work packages 
were carried out:
•  The PARTY+ Network addressed the implementation 
and enhancement of quality labels and charters for 
nightlife venues. Twenty-three new label processes 
were initiated with the support of Party+.
•  Techno Plus addressed field interventions during eight 
big party events in Europe, e.g. festivals. In total 92 
volunteers from 13 countries around Europe were in-
volved in these interventions. Volunteers offered harm 
reduction information and materials, chill-out areas, 
psychological support, drug checking services and ‘Se-
rious Video’ games.
•  The Emerging Media Work Package activity prepared 
the study of mediated interaction in several situations 
and with different technologies, with methods centred 
on the analysis of action along with more classic psy-
chological methods.
•  As part of the project, systematic drug checking was 
carried out by TEDI (Trans European Drug Informa-
tion) from 10 partner organisations in seven countries 
(Austria, Belgium, France, Germany, the Netherlands, 
Spain, Portugal). There were 458 new substances in the TEDI database (210 synthetic drugs were detected as 
well as 18 new adulterants). TEDI has made 6 contributions to the early warning system on new psychoactive 
substances. Results of the drug checking are regularly published in trend reports.
NEWIP provided four best-practice standards addressing peer education interventions in nightlife settings, drug 
checking services, safer nightlife labels and charters, and ‘serious games’ in nightlife settings. 
Webpages:
http://www.safernightlife.org
www.tediproject.org 
www.partyplus.eu 
Project presentation // http://ec.europa.eu/eahc/documents/health/presentation_2526112013_newip_en.pdf  
Duration :
 36 months (01/01/2011 to 31/12/2013)
EU Contribution : € 900 000.00
Project coordinators:
Stephane Leclercq
ABD, ES
StephaneLeclercqEU@gmail.com 
Partners:
Modus Vivendi, BE
Stichting Jellinek, NL
Suchtzentrum Leipzig (Drug Scouts), DE
University of Padova (HTLab), IT
APDES, PT
Techno Plus, FR
Verein Wiener Sozialprojekte (CHEcK iT!), AT
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European Network  
of Prosecutors Synthetic 
Drugs and Precursors II
A conference for European prosecutors was organised to discuss the entire synthetic drugs chain from 
the import and trade in raw materials and hardware to the production and sale of the end product.
The conference focused on new strategies and the 
Dutch ‘barrier-model’. The barrier-model shows the 
possibilities of how and where to put up barriers to the 
production of synthetic drugs in the Netherlands and 
worldwide.
The aims were to create an EU-wide network of national 
prosecutors sharing knowledge, skills, experiences and 
best practices, to introduce the Dutch barrier-model at 
European level as well as develop a strategy for multi-
disciplinary cooperation.
Duration :
 12 months (from 11/06/2010 to 
10/06/2011
EU Contribution : € 38 171.00
Project Coordinators :
Annemiek Heynens; 
National Public Prosecutor’s Office, NL
a.heynens@minjus.nl 
Prevention of and Fight against Crime (ISEC) 2007 – 2013 
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SAVE OUR NET (S.O.N.)
The S.O.N is an Italy-based project that aims to design new and effective means of Internet monitoring 
and discourage the sale and trafficking of NPS to minors on the Internet. 
From a conceptual point of view, the project provides 
for a balanced intervention on two levels: the first of a 
preventive-educational type and the second of a pre-
ventive-suppressing type.
Preventive-educational direction seeks to build a sys-
tem preventing minors from accessing websites that 
sell NPS online. The system would interact with the 
National Early Warning System (EWS) on New Psycho-
active Substances in order to update continuously in-
formation on dangerous websites. Additionally, the di-
rection includes educational awareness-raising actions 
targeting parents and educators.
Preventive-suppressing direction entails joint action 
among EWS, Central Directorate for Anti-drug Servic-
es of the Ministry of the Interior, Judicial Authority and 
interbank services institutes to monitor and update information on dangerous websites, and cooperation with 
law enforcement units to combat sale of NPS online.
Some of the results of the project are:
•  Gathered information on the profile of consumers who sell and buy NPS through the Internet.
•  Special software for parents to prevent minors from accessing websites which offer NPS, meanwhile allowing 
parents to report on dangerous websites to EWS.
• Informative and awareness-raising campaign for parents addressing potential risks on the Internet.
•  An experimental procedure involving cooperation between EWS and law enforcement units to intercept par-
cels of NPS addressed to minors.
• Study on legal framework in EU Member States to address NPS online selling to minors.
Websites:
www.allertadroga.it
Duration :
36 months (from 05/11/2011 to 03/11/2014)
EU Contribution : € 289 600.00 
Project coordinator:
Department for Antidrug Policies, IT  
Partners:
Central Directorate Antidrug Service, IT
Postal and Communication Police Service. IT
Addiction Department ULSS 20 of Verona, IT
Customs Agency, IT
The Sixth Framework Programme   
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CHAMP  
▶  Collaborative harmonisation of methods for profiling of amphetamine-type stimulants
The objectives of the project included development of harmonised profiling methods for ampheta-
mine-type stimulants (ATS) and a database with online access.
Except for actual amphetamines, information on ATS 
around the year 2000 was scarce and not much was 
known about harmonised chemical profiling methods for 
ATS such as ‘speed’ and MDMA (ecstasy). With MDMA, 
only in-house profiling methods existed. Profiling at in-
ternational level required transmission of the samples 
abroad, which made the procedure time-consuming and 
difficult. 
The project mainly focused on two different types of 
ATS, namely methamphetamine and MDMA, in order to 
develop methods required for reliable profiling of ATS. 
Additionally, during the research in laboratories, several 
new ATS were identified. Gathered data were used to 
develop minimum standards for identification of new 
ATS and results of the project allowed the profiling of 
drug seizures without sending samples to other labora-
tories. 
Whilst the project did not focus on new substances, 
data obtained from laboratories (methods such as GC/MS and GC/IRM) enriched the information not only about 
known substances, but also newly identified ones, and have been widely used in later research and studies.
Website:
http://ec.europa.eu/research/social-sciences/projects/208_en.html 
Articles:
L. Dujourdy et al.(2008) Drug intelligence based on organic impurities in illicit MA samples. Forensic Science 
International. Vol. 177, Issues 2–3, p. 153–161
C. Weyermann et al. (2008) Drug intelligence based on MDMA tablets data: I. Organic impurities profiling. Vol. 
177, Issue 1, p. 11–16
R. Marquis et al. (2008), Drug intelligence based on MDMA tablets data. 2. Physical characteristics profiling, 
Forensic Science International. Vol. 178, Issue 1, p. 34–39
Start: 
24 months ( 01/07/2004 to 30/06/2006)
 Project Coordinator:   
National Bureau of Investigation, 
Crime Laboratory, FI
EU Contribution: € 867 180.00
Partners:
Nederalnds Forensisch Instituut, NL
University of Lausanne, CH
Laboratoire de la Police Scientifique de Lyon, FR
Bundeskriminalamt, DE
Kriminalisticky Ustav Praha, CZ
Drug Enforcement Administration, US
The Seventh Framework Programme   
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PREDICT-IV  
▶  Profiling the toxicity of new drugs: a non animal-based approach integrating toxicody-
namics and biokinetics
The overall aim of the Predict-IV project was to develop strategies to improve the assessment of drug 
safety in the early stage of development and late discovery phase, by an intelligent combination of non 
animal-based test systems, cell biology, mechanistic toxicology and in-silico modelling, in a rapid and 
cost-effective manner. 
A better prediction of the safety of an investigational 
compound in early development was delivered, by ap-
plying advances in predictive toxicology (toxicogenom-
ics and metabolomics, prediction of pharmacokinetics 
and high content imaging) and modelling. Margins of 
safety were deduced and the data generated by the 
proposed approach may also identify early biomarkers 
of human toxicity for pharmaceuticals. The results ob-
tained from Predict-IV ought to enable pharmaceutical 
companies to create a tailored testing strategy for early 
drug safety.
 
The major advantages would be:
• reduced costs
• quicker turnaround times
•  low amount of compound needed for testing, enabling 
toxicity screening early
• in drug discovery (e.g., during lead optimisation)
•  early decisions on exclusion of candidates with unacceptable toxicity
•  knowledge-based selection of most promising lead candidates (late stage)
Website:
http://www.predict-iv.toxi.uni-wuerzburg.de/ 
Publications online:
http://www.predict-iv.toxi.uni-wuerzburg.de/media_events/publications_online/
Duration :
66 months (from 01/05/2008 to 31/10/2013)
EU Contribution : € 11 330 906
Project coordinators:
University of Würzburg
Department of Toxicology, DE
List of partner institutions:
 http://www.predict-iv.toxi.uni-wuerzburg.de/
participants/ 
The Seventh Framework Programme     
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ROSFEN  
▶  Rapid on-site forensic analysis of explosives and narcotics
The ROSFEN project is centred on delivering multiple technology innovations for fast on-site detection 
and direct analysis of explosive materials and narcotics. 
This novel platform removes the need for slow, costly 
chromatography methods currently used in lab-based 
analysis. ROSFEN will enable total analysis time (sam-
ples, blanks, controls) to be reduced from hours to min-
utes, thus alleviating the load on forensic labs and ena-
bling intelligence-led investigations.
ROSFEN will also innovate in the rapid analysis of new 
psychoactive drugs, by coupling the isomer selectivity 
of the ion filter technique with the detection sensitivity 
of tandem mass spectrometry. ROSFEN will thus ena-
ble European industry to develop and deliver innovative 
technologies into key global markets: Analytical instru-
ments for security applications ($ 2 billion annually) 
and the $ 3.3 billion market for mass spectrometry. 
The ROSFEN consortium comprises two research-inten-
sive SMEs, two leading research groups and two end us-
ers. The end users have decades of expertise in forensic 
analysis of explosives and narcotics (FSNI), as well as 
crime scene analysis (PSNI). 
Website:
www.rosfen.eu 
Duration: 
24 months (01/04/2013 to 31/03/2015)
 EU Contribution: € 1 420 262
Project Coordinator: 
University College Cork,
National University of Ireland, IE
Partners:
Microsaic Systems, UK
Environics OY, FI
University of Basel, CH
 Department of Justice, Forensic Science Northern 
Ireland, UK
Police Service of Northern Ireland, UK
The Seventh Framework Programme   
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ALICE RAP 
▶  Addiction and lifestyles in contemporary Europe – Reframing addictions project
ALICE RAP is a five-year European research project that brings together over 100 scientists from more 
than 25 countries and 29 different disciplines. It aims to analyse the challenges posed by addictive legal 
and illegal substances and lifestyles to the cohesion, organisation and functioning of contemporary Eu-
ropean society.
The project is divided into seven areas and 21 work 
packages (three in each area), making up an integrated 
multidisciplinary research strategy, encompassing his-
tory of addiction, classification and definition of addic-
tions, policy analyses, the business of addiction, youth 
as customers, the impacts of new technologies on use, 
the interrelations of culture and biology and many other 
aspects. The results of the research, conferences and 
meetings are publicly available on the project’s web-
page.
Two work packages in ALICE-RAP investigate NPS:
•  Researchers at the Institute of Psychiatry (UK) are 
carrying out a semi-systematic review of the Internet 
marketing of illicit drugs and ‘legal highs’ and analys-
ing trends over five years. The work aims to identify 
more than 100 websites and analyse their marketing 
practices.
•  As part of a broader work package, 16 researchers from Liverpool Moores University (UK) have investigated 
the evidence base of policies designed to respond to young people’s participation in addictive behaviours 
(including use of NPS). The findings from this work are to be summarised in a framework for identifying the 
impact of young people’s policy and made available through an electronic database. As part of this, at the 
end of 2013 the Policy Paper on Novel Psychoactive Substances was published, providing information on 
situations and policy responses.
Website:
http://www.alicerap.eu
Working package 16// http://alice-rap.prevention-standards.eu/ 
 
Articles:
Policy Paper 3 - Novel Psychoactive Substances. Nov 2013 
http://www.alicerap.eu/resources/documents/cat_view/1-alice-rap-project-documents/19-policy-paper-series.html 
Duration :
60 months (from 01/04/2011 to 31/03/2016)
 Project coordinator: 
Hostipal Clinic Barcelona, ES
EU Contribution: € 7 978 226
 The list of participants  
and partner institutions  
available here:
 http://www.alicerap.eu/about-alice-rap/part-
ner-institutions.htmlublished   
Other 
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DROSICAN
▶  Support for the Andean Community in the area of synthetic drugs
The aim of the project was to propose methodologies and tools for prevention and control of possible 
effects of the supply of and demand for illicit synthetic drugs in the Andean Community, by forming stra-
tegic partnerships with community organisations, civil society, and public and private agencies. . 
Within the framework of the project studies on drug use 
among students in Bolivia, Colombia, Ecuador and Peru 
were conducted, revealing public health risks and asso-
ciated factors.
As a result of the project, close to 3 100 health, educa-
tional, police, legal and customs professionals, among 
others, were given specialised training in the different 
areas of synthetic drug supply and demand through 50 
training events offered during the course of the project. 
Furthermore, the Andean Community countries were 
given assistance in strengthening their national obser-
vatories from the conceptual, methodological and oper-
ational viewpoints, with a view to their adoption of pub-
lic policies based on scientific information and evidence. 
Experts from EU countries provided knowledge and re-
search regarding the use of new synthetic drugs and 
the structures and nomenclature of ‘designer drugs’. 
The EMCDDA complemented this with a description of 
its monitoring of new psychoactive substances and a 
presentation of the EU Early Warning System on NPS.
Networks had been formed of governmental and non-governmental institutions concerned with drug use, 
which promoted information sharing and experiences and coordinated actions in the areas of synthetic drug 
supply and demand. 
Reports:
Epidemiologic Study on Public Health and Associated Factors of College Students in the Andean Countries 
(2009)// http://www.comunidadandina.org/DS/DROSICAN/Estudio%20universitario%20Regional%20ingles.pdf 
Informe Final Memoria del Proyecto Drosican (2010)// 
http://www.comunidadandina.org/DS/DROSICAN/MEMORIA_DROSICAN_ok.pdf
Duration: 
 21 months (from 30/09/2008 to 
01/05/2010)
 EU Contribution (Development  
Cooperation Instrument):  
€ 2 500 000
Project Coordinator: 
Tatiana Dalence Montaño,
 General secretariat of Andean Community, 
Peru
Countries:
Bolivia
Columbia
Ecuador
Peru
EU financial programmes 2014-2020 
   
Justice Programme 2014-2020
The Justice Programme, which aims at contributing to the further development of a European area of justice, 
will fund projects relating to drugs, including new psychoactive substances. It has a budget of € 378 million.
http://ec.europa.eu/justice/grants1/programmes-2014-2020/justice/index_en.htm
The Internal Security Fund 2014-2020
The Internal Security Fund, which supports the implementation of the Internal Security Strategy, can pro-
vide funding for projects relating to drug supply – including regarding new psychoactive substances. It has a 
budget of around € 1 billion.
http://ec.europa.eu/dgs/home-affairs/financing/fundings/funding-home-affairs-beyond-2013/index_en.htm
The Health Programme 2014-2020
The Health Programme, whose objective is to promote health, prevent diseases and foster supportive envi-
ronments for healthy lifestyles, will support health-related drug projects. It has a budget of € 449.4 million.
http://ec.europa.eu/health/programme/policy/index_en.htm
Horizon 2020
Horizon 2020 is the EU’s Research and Innovation programme, with a budget of nearly € 80 billion. Its 
‘Health, demographic change and wellbeing’ component will be able to fund research relevant to new psy-
choactive substances – for instance to develop innovative approaches to testing. 
http://ec.europa.eu/programmes/horizon2020/en
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